Skip to main content
. 2020 May 19;10:756. doi: 10.3389/fonc.2020.00756

Table 1.

Clinical information of patients included in current study and their tumor characteristics.

Cohort I N = 44 primary and 44 LNM %
Age, y
   Median age 52 y
   Range 32–74 y
Gender
   Female 44 100%
Stage
   I 0 00.0%
   II 25 56.8%
   III 14 31.8%
   IV 5 11.4.0%
Molecular subtype
   Luminal 37 84.0%
   HER2 3 06.8%
   TN 4 09.0%
Hormone status
   ER 36 81.8%
   PR 33 75.0%
   HER2 10 22.7%